SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-04-006427
Filing Date
2004-11-16
Accepted
2004-11-16 17:29:29
Documents
1
Period of Report
2004-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 12241
  Complete submission text file 0001140361-04-006427.txt   14210
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 212-531-5965
Salomon Peter (Reporting) CIK: 0001294422 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-16929 | Film No.: 041150385